Inventor · Sunnyvale, CA, US

David Scott Carter

16Patents
6h-index
31Co-inventors
66Inventor score

Filing activity: Jan 29, 1975 → Dec 1, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7858632B2 Diaminopyrimidines as P2X3 and P2X2/3 antagonists Human Necessities 15 Active
US5739336A 1,3,8-triaza- and 3,8-diaza-1-oxaspiro 4,5! decane derivatives Chemistry; Metallurgy 15 Expired
US4006245A Chemical compounds Human Necessities 11 Expired
US8273773B2 Heterocyclic antiviral compounds Chemistry; Metallurgy 10 Active
US4133889A 2(5-Tetrazolyl)chromones Chemistry; Metallurgy 9 Expired
US8008313B2 Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases Human Necessities 6 Active
US8846705B2 Diaminopyrimidines as P2X3 and P2X2/3 antagonists Human Necessities 4 Active
US8524725B2 Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseases Human Necessities 1 Active
US7754721B2 Arylpiperazine derivatives and uses thereof Chemistry; Metallurgy 1 Active
US10562921B2 Oxaborole esters and uses thereof Emerging Cross-Sectional Technologies 1 Active
US10882872B2 Oxaborole esters and uses thereof Emerging Cross-Sectional Technologies 0 Active
US9556127B2 Diaminopyrimidines as P2X3 and P2X2/3 antagonists Human Necessities 0 Active
US11578087B2 Oxaborole esters and uses thereof Emerging Cross-Sectional Technologies 0 Active
US10947196B2 Beta adrenergic agonist and methods of using the same Chemistry; Metallurgy 0 Active
US11040944B2 Beta adrenergic agonist and methods of using the same Chemistry; Metallurgy 0 Active
US7998963B2 Arylpiperazine derivatives and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.